0 NASDAQ Companies - October 20, 2020CENTOGENE Announces Leadership TransitionCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 20, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]Read More
0 NASDAQ Companies - October 20, 2020CENTOGENE Increases Full-Year 2020 GuidanceCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, Oct. 20, 2020 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG), a commercial-stage company […]Read More
0 NASDAQ Companies - October 20, 2020eToro Chooses Nasdaq to Expand U.S. Market Insight for Global InvestorsNEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that it is providing real-time market data […]Read More
0 NASDAQ Companies - October 20, 2020Top Executives in France Paying More Attention to Cyber SecurityPARIS, Oct. 20, 2020 (GLOBE NEWSWIRE) — Enterprises in France are changing their approach to cyber security, with top executives […]Read More
0 NASDAQ Companies - October 20, 2020Volkswagen Adopts NXP Battery Management Solutions for its MEB Electrical Vehicle PlatformVolkswagen’s newly launched ID series, powered by its groundbreaking MEB platform, is pressing the boundaries of Electrical Vehicle (EV) travelNXP […]Read More
0 NASDAQ Companies - October 20, 2020NXP Extends its Secure Ultra-Wideband Portfolio with New Sensing Solutions that Enable Emerging IoT Use CasesNew IoT ICs deliver highly precise positioning capabilities and fine ranging for IoT applications such as smart locks and IoT […]Read More
0 NASDAQ Companies - October 20, 2020Vifor Pharma and Cara Therapeutics sign US license agreement for IV Korsuva™* to treat dialysis patients with pruritusVifor Pharma secures commercial rights for IV Korsuva in non-Fresenius Medical Care dialysis clinics representing approx. 66% of the market, […]Read More
0 NASDAQ Companies - October 20, 2020ObsEva SA Presented Nolasiban Poster at the ASRM 2020 Virtual Scientific Congress October 17-21 Geneva, Switzerland and Boston, MA – October 20, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and […]Read More
0 NASDAQ Companies - October 19, 2020UPDATE — Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020Bay Street NewsRead More
0 NASDAQ Companies - October 19, 2020UPDATE — Iterum Therapeutics to Present Data from Phase 3 Trials in Uncomplicated and Complicated Urinary Tract Infections at IDWeek 2020Bay Street NewsRead More